Literature DB >> 19196071

Interferon-gamma regulation of intestinal epithelial permeability.

Cécile Beaurepaire1, David Smyth, Derek M McKay.   

Abstract

The maintenance and regulation of the barrier function of the epithelial lining of the intestine are important homeostatic events, serving to allow selective absorption from the gut lumen while simultaneously limiting the access of bacteria into the mucosa. Interferon-gamma is a pleiotrophic cytokine produced predominantly by natural kill cells and CD4+ T cells that under normal circumstances, and particularly during infection or inflammation, will be a component of the intestinal milieu. Use of colon-derived epithelial cell lines and, to a less extent, murine in vivo analyses, have revealed that interferon-gamma (IFN-gamma) can increase epithelial permeability as gauged by markers of paracellular permeability and bacterial transcytosis, with at least a portion of the bacteria using the transcellular permeation pathway. In this review, we describe the main characteristics of epithelial permeability and then focus on the ability of IFN-gamma to increase epithelial permeability, and the mechanism(s) thereof.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19196071     DOI: 10.1089/jir.2008.0057

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  42 in total

1.  Spermidine stimulates T cell protein-tyrosine phosphatase-mediated protection of intestinal epithelial barrier function.

Authors:  Harrison M Penrose; Ronald R Marchelletta; Moorthy Krishnan; Declan F McCole
Journal:  J Biol Chem       Date:  2013-09-10       Impact factor: 5.157

2.  Inflammatory signaling in NEC: Role of NF-κB, cytokines and other inflammatory mediators.

Authors:  Catherine J Hunter; Isabelle G De Plaen
Journal:  Pathophysiology       Date:  2013-12-31

Review 3.  Inflammatory signaling in necrotizing enterocolitis.

Authors:  Isabelle G De Plaen
Journal:  Clin Perinatol       Date:  2013-01-17       Impact factor: 3.430

4.  Brief Report: Inflammatory Colonic Innate Lymphoid Cells Are Increased During Untreated HIV-1 Infection and Associated With Markers of Gut Dysbiosis and Mucosal Immune Activation.

Authors:  Stephanie M Dillon; Moriah J Castleman; Daniel N Frank; Gregory L Austin; Sara Gianella; Andrew C Cogswell; Alan L Landay; Edward Barker; Cara C Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2017-12-01       Impact factor: 3.731

Review 5.  Brain-Gut-Bone Marrow Axis: Implications for Hypertension and Related Therapeutics.

Authors:  Monica M Santisteban; Seungbum Kim; Carl J Pepine; Mohan K Raizada
Journal:  Circ Res       Date:  2016-04-15       Impact factor: 17.367

6.  Critical Role for the Microbiota in CX3CR1+ Intestinal Mononuclear Phagocyte Regulation of Intestinal T Cell Responses.

Authors:  Myunghoo Kim; Carolina Galan; Andrea A Hill; Wan-Jung Wu; Hannah Fehlner-Peach; Hyo Won Song; Deborah Schady; Matthew L Bettini; Kenneth W Simpson; Randy S Longman; Dan R Littman; Gretchen E Diehl
Journal:  Immunity       Date:  2018-07-03       Impact factor: 31.745

7.  VSL#3 Probiotic Stimulates T-cell Protein Tyrosine Phosphatase-mediated Recovery of IFN-γ-induced Intestinal Epithelial Barrier Defects.

Authors:  Moorthy Krishnan; Harrison M Penrose; Nilay N Shah; Ronald R Marchelletta; Declan F McCole
Journal:  Inflamm Bowel Dis       Date:  2016-12       Impact factor: 5.325

8.  AMP-activated protein kinase mediates the interferon-gamma-induced decrease in intestinal epithelial barrier function.

Authors:  Michael Scharl; Gisela Paul; Kim E Barrett; Declan F McCole
Journal:  J Biol Chem       Date:  2009-08-04       Impact factor: 5.157

9.  IL-1β promotes the differentiation of polyfunctional human CCR6+CXCR3+ Th1/17 cells that are specific for pathogenic and commensal microbes.

Authors:  Thomas Duhen; Daniel J Campbell
Journal:  J Immunol       Date:  2014-06-02       Impact factor: 5.422

10.  Disrupted tight junctions in the small intestine of cystic fibrosis mice.

Authors:  Robert C De Lisle
Journal:  Cell Tissue Res       Date:  2013-10-30       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.